ENPP7P13

Across TCGA pan-cancer cohorts, ENPP7P13 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated ENPP7P13 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ENPP7P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ENPP7P13 expression acts as an unfavorable survival marker.

BLCA, THYM, and TGCT are the cancer types where ENPP7P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.166	0.610	.001	135	view →
THYM	OS	Tertile	II,III,IV	0.169	0.905	<.001	45	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	36	view →
LIHC	DFS	Tertile	All	0.452	0.589	.001	35	view →
SKCM	DFS	Tertile	IV	0.040	0.454	.028	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ENPP7P13–BLCA (OS)

Open the BLCA breakdown →